SciNeuro Pharmaceuticals and Alamar Biosciences Collaborate to Discover Novel Therapeutic Antibodies for CNS Diseases
FREMONT, Calif. and ROCKVILLE, Md., Feb. 15, 2022 /PRNewswire/ — Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and SciNeuro Pharmaceuticals (SciNeuro), a leader in the discovery…
Comments Off on SciNeuro Pharmaceuticals and Alamar Biosciences Collaborate to Discover Novel Therapeutic Antibodies for CNS Diseases